Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.84 -0.09 (-0.31%)
Official Closing Price Updated: 7:00 PM EDT, Oct 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,036,428
Open 28.90
Bid (Size) 28.87 (20)
Ask (Size) 28.93 (3)
Prev. Close 28.93
Today's Range 28.60 - 28.98
52wk Range 25.20 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 5.69%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
From Pfizer Inc.
Via Business Wire
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions
Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets since the COVID-19 boom. 
Via Benzinga
Exposures COVID-19

Performance

YTD
-2.99%
-2.99%
1 Month
-1.60%
-1.60%
3 Month
-2.24%
-2.24%
6 Month
+9.57%
+9.57%
1 Year
-6.49%
-6.49%

More News

Read More
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
Via Benzinga
Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises
Via Investor's Business Daily
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
Via The Motley Fool
Nvidia Among Five Best S&P 500 Stocks Today
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Three AI Stocks That Could Beat Nvidia After Today
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Via The Motley Fool
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Via The Motley Fool
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
Via Benzinga
Why I'm Considering Leaning Heavily Into Pfizer
Via The Motley Fool
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Tim Buckley Elected to Pfizer’s Board of Directors
From Pfizer Inc.
Via Business Wire
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Via The Motley Fool
2 Ultra-High-Yield Dividend Stocks With Total Return Potential of Up to 92% in 12 Months, According to Select Wall Street Analysts
Via The Motley Fool
The Bull's Biggest Hits And Misses
Via Talk Markets
Topics Stocks
Exposures US Equities
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Via Talk Markets
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
Via Investor's Business Daily
Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?
Via The Motley Fool
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Via Benzinga
Exposures Product Safety
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
Via The Motley Fool
Topics Stocks
Exposures US Equities
2 Unstoppable Growth Stocks to Buy Right Now for Less than $200
Via The Motley Fool
2 Incredibly Cheap Big Pharma Stocks to Buy Now
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.